References
- Ball P., Tillotson G. Tolerability of fluoroquinolone antibiotics. Past, present, and future. Drug Safety 1995; 13: 343–358
- Bailey J.R., Trott S.A., Philbrick J.T. Ciprofloxacin-induced acute interstitial nephritis. Am. J. Nephrol. 1992; 12: 271–273
- Allon M., Lopez E.J., Min K.W. Acute renal failure due to ciprofloxacin. Arch. Intern. Med. 1990; 150: 2187–2189
- Hootkins R., Fenves A.Z., Stephens M.K. Acute renal failure secondary to oral ciprofloxacin: a presentation of three cases and a review of the literature. Clin. Nephrol. 1989; 32: 75–78
- Mackay A.D., Mehta A. Autoimmune hemolytic anaemia associated with ciprofloxacin. Clin. Lab. Haematol. 1995; 17: 97–98
- Kundu A.K. Ciprofloxacin-induced severe cutaneous reaction and haemolysis in a young adult. J. Assoc. Physicians India 2000; 48: 649–650
- Schacht P., Hullmann R. Safety of oral ciprofloxacin. An update based on clinical trial results. Am. J. Med. 1989; 87(suppl 5A)98–102
- Andrews P.A., Robinson G.T. Intravascular hemolysis and interstitial nephritis in association with ciprofloxacin. Nephron 1999; 83: 359–360
- Baldwin D.S., Levine B.B., McCluskey R.T., Gallo G.R. Renal failure and interstitial nephritis due to penicillin and methicillin. N. Engl. J. Med. 1968; 279: 1245–1252
- Ten R.M., Torres V.E., Milliner D.S., Schwab T.R., Holley K.E., Gleich G.J. Acute interstitial nephritis: immunologic and clinical aspects. Mayo Clin. Proc. 1988; 63: 921–930
- Ruffing K.A., Hoppes P., Blend D., Cugino A., Jarjoura D., Whittier F.C. Eosinophils in urine revisited. Clin. Nephrol. 1994; 41: 163–166
- Michel D.M., Kelly C.J. Acute interstitial nephritis. J. Am. Soc. Nephrol. 1998; 9: 506–515
- Toto R.D. Acute tubulointerstitial nephritis. Am. J. Med. Sci. 1990; 299: 392–410
- Neilson E.G. Pathogenesis and therapy of interstitial nephritis. Kidney Int. 1989; 35: 1257–1270
- Pusey C.D., Saltissi D., Bloodworth L., Rainford D.J., Christie J.L. Drug associated acute interstitial nephritis: clinical and pathological features and the response to high dose steroid therapy. Q. J. Med. 1983; 52: 194–211
- Gilbertson C., Jones D.R. Haemolytic anaemia with nalidixic acid. B.M.J. 1972; 4: 493
- Tafani O., Mazzoli M., Landini G., Alterini B. Fatal acute immune haemolytic anaemia caused by nalidixic acid. B.M.J. Clin. Research Ed. 1982; 285: 936–937
- Gordon-Smith E.C. Drug-induced oxidative haemolysis. Clin. Hematol. 1980; 9: 557–586
- Petz L.D. Drug-induced immune haemolytic anemia. Clin. Hematol. 1980; 9: 455–481